A shadow economy for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to message these profiles directly for supplier links, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and claims of rapid British shipping. Sellers promote the substance there before directing buyers to other platforms for purchases.
Learning About Retatrutide
This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Worries
However, physicians and chemists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in users injecting substances of unknown origin.
Some experts said the demand for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.
Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or prison.
Platform Response and Material Elimination
According to TikTok, the platform has taken down problematic content and prohibited related keywords and search suggestions. The organization stated it was committed to keeping the platform safe and investing in enhancing compliance measures.
Online Marketplace Operations
Research also discovered groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, glowing reviews and step-by-step instructions for mixing or administering at home.
After minutes of entering one community, a seller shared WhatsApp details, where the majority of transactions occur. The seller provided an guidebook and promised delivery within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, medical conditions or past usage.
Item Information and Costs
Inside these communities, posts display black plastic parcels with postal service stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When asked how long a injector should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A representative for Telegram stated it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering substances they can’t verify. Although the science behind this drug is valid, these digital versions may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has already seen individuals harmed by personal administration from unverified suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose users to possibly significant health risks”.
